EDGEWISE THERAPEUTICS INC EWTX
COM · Common Stock · CUSIP 28036F105
- SectorHealth care
- IndustryPharmaceutical Preparations
- HeadquartersBoulder, CO
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 49.3m as of 2021-07-30, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $21.48.
Trends to Q2 2021
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q1 2021 | 32 |
| Q2 2021 | 47 |
Biggest buyers
| FMR LLC | Added | +884.8k |
| Cormorant Asset Management, LP | Added | +800.0k |
| BlackRock Inc. | Added | +512.0k |
| VANGUARD GROUP INC | Added | +462.9k |
| GEODE CAPITAL MANAGEMENT, LLC | New | +242.4k |
| STATE STREET CORP | New | +177.5k |
| Logos Global Management LP | Added | +175.0k |
| CREDIT SUISSE AG/ | Added | +127.1k |
| NORTHERN TRUST CORP | New | +126.7k |
| FEDERATED HERMES, INC. | Added | +83.3k |
Biggest sellers
| VIKING GLOBAL INVESTORS LP | Reduced | -625.0k |
| JANUS HENDERSON GROUP PLC | Reduced | -351.6k |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | Sold out | -300.0k |
| NORGES BANK | Reduced | -147.3k |
| SPHERA FUNDS MANAGEMENT LTD. | Sold out | -100.0k |
| Soleus Capital Management, L.P. | Reduced | -68.7k |
| GOLDMAN SACHS GROUP INC | Sold out | -65.3k |
| MILLENNIUM MANAGEMENT LLC | Sold out | -60.1k |
| CAAS CAPITAL MANAGEMENT LP | Sold out | -30.0k |
| Squarepoint Ops LLC | Sold out | -20.2k |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
ORBIMED ADVISORS LLC
13D · may seek influence
filed 2025-05-12
Stated purposeThe Reporting Persons from time to time intend to review their investment in the Issuer on the basis of various factors, including the Issuer's business, financial condition, results of operations and prospects, general economic and industry conditions, the securities markets in general and those for the Issuer's Shares in particular, as well as other developments and other investment opportunities. Based upon such review, the Reporting Persons will take such actions in the future as the Reporting Persons may deem appropriate in light of the circumstances existing from time to time. If the Reporting Persons believe that further investment in the Issuer is attractive, whether because of the market price of Shares or otherwise, they may acquire Shares or other securities of the Issuer either… Full filing |
14.5% |
| Paradigm Biocapital Advisors LP 13G · passive investor +3.3 pts · filed 2026-08-14 | 9.5% |
| RA CAPITAL MANAGEMENT, L.P. 13G · passive investor -2.1 pts · filed 2026-08-14 | 7.8% |
| JANUS HENDERSON GROUP PLC 13G · institution +0.8 pts · filed 2026-05-15 | 5.5% |
| BlackRock, Inc. 13G · institution filed 2025-07-17 | 5.5% |
| FMR LLC 13G · institution new · filed 2026-08-06 | 5.1% |
Fell to 5% or below in the last year: BAKER BROS. ADVISORS LP (3.4%, 2026-08-14), Novo Holdings A/S (4.9%, 2026-04-27)
Insider purchases and sales in Q2 2021
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
Officers and directors buying vs selling
Number of people, by quarter (10% owners not included)
Numbers
| Quarter | Buying | Bought | Selling | Sold | Sold under a plan |
|---|---|---|---|---|---|
| Q3 2019 | 0 | — | 0 | — | — |
| Q4 2019 | 0 | — | 0 | — | — |
| Q1 2020 | 0 | — | 0 | — | — |
| Q2 2020 | 0 | — | 0 | — | — |
| Q3 2020 | 0 | — | 0 | — | — |
| Q4 2020 | 0 | — | 0 | — | — |
| Q1 2021 | 3 | $6.0m | 0 | — | — |
| Q2 2021 | 0 | — | 0 | — | — |
None reported in Q2 2021.
Holders, Q2 2021
| Manager | Shares | Change |
|---|---|---|
| ORBIMED ADVISORS LLC 3.02% of their portfolio | 13.9m $297.4m | Unchanged |
| NOVO HOLDINGS A/S 5.29% of their portfolio | 5.6m $119.2m | Unchanged |
| DEERFIELD MANAGEMENT COMPANY, L.P. 1.49% of their portfolio | 3.9m $83.9m | Unchanged |
| Cormorant Asset Management, LP 2.59% of their portfolio | 3.1m $66.5m | Added +800.0k |
| VIKING GLOBAL INVESTORS LP 0.18% of their portfolio | 2.7m $58.2m | Reduced -625.0k |
| RA CAPITAL MANAGEMENT, L.P. 0.89% of their portfolio | 2.6m $55.7m | Unchanged |
| CITADEL ADVISORS LLC 0.05% of their portfolio | 2.5m $51.2m | Added +78.0k |
| FMR LLC 0.00% of their portfolio | 2.4m $51.5m | Added +884.8k |
| JANUS HENDERSON GROUP PLC 0.02% of their portfolio | 1.8m $36.7m | Reduced -351.6k |
| New Leaf Venture Partners, L.L.C. 11.24% of their portfolio | 1.6m $43.8m | Unchanged |
| Logos Global Management LP 2.25% of their portfolio | 1.2m $26.3m | Added +175.0k |
| EcoR1 Capital, LLC 0.98% of their portfolio | 1.2m $26.1m | Unchanged |
| WELLINGTON MANAGEMENT GROUP LLP 0.00% of their portfolio | 741.6k $15.5m | Reduced -824 |
| FEDERATED HERMES, INC. 0.03% of their portfolio | 700.0k $14.9m | Added +83.3k |
| VANGUARD GROUP INC 0.00% of their portfolio | 582.9k $12.4m | Added +462.9k |
| BlackRock Inc. 0.00% of their portfolio | 567.5k $12.1m | Added +512.0k |
| BAKER BROS. ADVISORS LP 0.05% of their portfolio | 500.0k $10.7m | Unchanged |
| Woodline Partners LP 0.14% of their portfolio | 354.5k $7.6m | Reduced -2.9k |
| NORGES BANK 0.00% of their portfolio | 301.7k $6.4m | Reduced -147.3k |
| AMERICAN CENTURY COMPANIES INC 0.00% of their portfolio | 294.3k $6.3m | Added +15.7k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 242.4k $5.2m | New |
| CREDIT SUISSE AG/ 0.00% of their portfolio | 211.2k $4.5m | Added +127.1k |
| STATE STREET CORP 0.00% of their portfolio | 177.5k $3.8m | New |
| NORTHERN TRUST CORP 0.00% of their portfolio | 126.7k $2.7m | New |
| Octagon Capital Advisors LP 0.55% of their portfolio | 125.0k $2.7m | Unchanged |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.00% of their portfolio | 81.1k $1.7m | New |
| Nuveen Asset Management, LLC 0.00% of their portfolio | 46.8k $999.0k | New |
| D. E. Shaw & Co., Inc. 0.00% of their portfolio | 46.2k $985.0k | New |
| Soleus Capital Management, L.P. 0.10% of their portfolio | 31.3k $668.0k | Reduced -68.7k |
| Bank of New York Mellon Corp 0.00% of their portfolio | 28.5k $607.0k | New |
| HighVista Strategies LLC 0.42% of their portfolio | 27.5k $586.0k | New |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 0.00% of their portfolio | 17.0k $363.0k | New |
| NEW YORK STATE COMMON RETIREMENT FUND 0.00% of their portfolio | 10.6k $226.0k | New |
| JPMORGAN CHASE & CO 0.00% of their portfolio | 10.1k $216.0k | New |
| Pinz Capital Management, LP 0.06% of their portfolio | 8.7k $186.0k | New |
| DEUTSCHE BANK AG\ 0.00% of their portfolio | 7.3k $156.0k | New |
| AMERICAN INTERNATIONAL GROUP, INC. 0.00% of their portfolio | 6.9k $147.0k | New |
| STRS OHIO 0.00% of their portfolio | 2.9k $61.0k | New |
| Legal & General Group Plc 0.00% of their portfolio | 1.9k $40.0k | New |
| Ameritas Investment Partners, Inc. 0.00% of their portfolio | 967 $21.0k | New |
| UBS Group AG 0.00% of their portfolio | 868 $19.0k | New |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 844 $18.0k | New |
| CITIGROUP INC 0.00% of their portfolio | 587 $13.0k | New |
| MORGAN STANLEY 0.00% of their portfolio | 462 $10.0k | New |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 294 $6.0k | New |
| State of Wyoming 0.00% of their portfolio | 42 $1.0k | New |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |